RGLS4326 Granted Orphan Drug Designation for Treatment of ADPKD
Photo by Robina Weermeijer on Unsplash

RGLS4326 Granted Orphan Drug Designation for Treatment of ADPKD

  In a recent press release, biopharmaceutical company Regulus Therapeutics, Inc. announced that their drug candidate, RGLS4326, received Orphan Drug Designation for the treatment of autosomal dominant polycystic kidney disease…

Continue Reading RGLS4326 Granted Orphan Drug Designation for Treatment of ADPKD
Three Young People With Chronic Illness Talk About the Challenges They Face
source: pixabay.com

Three Young People With Chronic Illness Talk About the Challenges They Face

  Three people with an eye on the future talk about their innermost feelings and the fact that their lives may be interrupted at any time by their chronic illness.…

Continue Reading Three Young People With Chronic Illness Talk About the Challenges They Face